A Multi-center 12-week Study of HMS5552 in T2DM

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This study evaluates the safety, tolerability, efficacy and population PK of HMS5552 in type 2 diabetic adult subjects,there will be 5 groups ,4 groups will receive HMS5552,while 1 will receive placebo.
Epistemonikos ID: ae7193c170c4559ef5fed22da692767e5ad2ce91
First added on: May 12, 2024